Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Tocilizumab ttIL6.php on line 2
Tocilizumab ttIL6
LE WE PMID CA
Tocilizumab ttIL64137Tocilizumab ttIL6

81C6 ttTenascin

Abatacept ttCTLA4Conjugate

Abciximab ttGPIIAIIIB

Adalimumab ttTNFalpha

AIN457

Alefacept

Alemtuzumab ttCD52

AMG386 ttAngiopoietin1 ttAngiopoietin2

Antibodies (therapeutic use)

Arthritis (juvenile idiopathic)

Arthritis (rheumatoid)

Atacicept ttBlys ttAPRIL

Bapineuzumab ttAmyloidBeta

Basiliximab ttIL2R

Belatacept ttCD80 ttCD86

Belimumab ttBLyS

Bevacizumab ttVEGF

Brentuximab vedotin ttCD30

Briakinumab ttIL12 ttIL23

Canakinumab ttIL1beta

Catumaxomab ttEpCAM ttCD3 linkerAb

Certolizumab ttTNFalpha

Cetuximab ttEGFR

Daclizumab ttIL2R

Dalotuzumab ttIGF1R

Denosumab ttRANKL

Eculizumab ttFactorH

Efalizumab ttLFA1

Epratuzumab ttCD22

Etanercept ttTNFalpha

FactorIXFc ttFactorIX

FactorVIIIFc ttFactorVIII

Farletuzumab ttFolateRalpha

Figitumumab ttIGF1R

Galiximab ttCD80

Gemtuzumab ozogamicin ttCD33

Girentuximab ttCarbonicAnhydraseIX

Golimumab ttTNFalpha

Ibritumomab tiuxentan yttrium ttCD20

Immunosuppressive agents

Inflammation (BASKET)

Infliximab ttTNFalpha

Inotuzumab ozogamicin ttCD22

Ipilimumab ttCTLA4

Mepolizumab ttIL5

Motavizumab ttRSVirus

MuromonabCD3 ttCD3

Naptumomab estafenatox tt5T4

Natalizumab ttIntegrinalpha4

Necitumumab ttEGFR

Nimotuzumab ttEGFR

Obinutuzumab ttCD20

Ocrelizumab ttCD20

Ofatumumab ttCD20

Omalizumab ttCD20

Otelixizumab ttCD3

Pagibaximab ttLipoteichoicAcidStaphlococcus

Palivizumab ttRSVirusFprotein

Panitumomab ttEGFR

Pertuzumab ttHER2

Psoriasis

QPI1002 ttp53

Ramucirumab ttVEGFR2

Ranibizumab ttVEGF

Raxibacumab ttAnthrax

Receptor (Interleukin6 GP130)

REGN88 ttIL6R

Repertaxin ttCXCR1 ttCXCR2

Reslizumab ttIL5

Rilonacept ttIL1R

Rituximab ttCD20

RPSGLIG ttPSelectin

Solanezumab ttAmyloidBeta

T1H ttCD6

Tanezumab ttNGF

Teplizumab ttCD3

Tocilizumab ttIL6

Tositumomab ttCD20

TP10 ttsCR3

Transplantation

Trastuzumab emtansine ttHER2

Trastuzumab ttHER2

Tremelimumab ttCLTA4

Ustekinumab ttIL12 ttIL23

Vedolizumab ttIntegrina4b7

Zalutumumab ttEGFR

Zanulimumab ttCD4

2008  
1
Review of tocilizumab in the treatment of rheumatoid arthritis.
[19707430] Biologics 2(1): 75-82 (2008)
2010  
2
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.
[20635831] J Manag Care Pharm 16(6): 402-16 (2010)
2007  
3
Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases.
[17978466] Biol Pharm Bull 30(11): 2001-6 (2007)
2010  
4
Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.
[20421913] Ther Clin Risk Manag 6(): 143-52 (2010)
2010  
5
Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis.
[20694074] Core Evid 4(): 181-9 (2010)
2010  
6
Tocilizumab - a new step in rheumatoid arthritis treatment.
[20975633] Acta Reumatol Port 35(3): 302-12 (2010)
2007  
7
Interleukin-6 inhibition--tolerability profile and clinical implications.
[17708741] Bull NYU Hosp Jt Dis 65 Suppl 1(-): S21-4 (2007)
2011  
8
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.
[21881215] J Clin Invest 121(9): 3375-83 (2011)
2010  
9
Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.
[21116333] Drug Des Devel Ther 4(-): 263-78 (2010)
2011  
10
Antibody-based therapeutics to watch in 2011.
[21051951] MAbs 3(1): 76-99 (2011)
2010  
11
Antibody immunosuppressive therapy in solid organ transplant: Part II.
[20948291] MAbs 2(6): 607-12 (2010)
2010  
12
Antibodies to watch in 2010.
[20065640] MAbs 2(1): 84-100 (2010)
2009  
13
2009  
14
Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis.
[19590933] Mod Rheumatol 19(4): 351-7 (2009)
2010  
15
Tocilizumab: a review of its safety and efficacy in rheumatoid arthritis.
[21234291] Clin Med Insights Arthritis Musculoskelet Disord 3(): 81-9 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Tocilizumab ttIL6.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Tocilizumab ttIL6.php on line 92